癫痫市场基于(关键地区、市场参与者、规模和份额)- 到 2030 年的预测

  • Report Code : TIPRE00016405
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 230
Buy Now

【研究报告】癫痫市场规模预计将从2022年的77亿美元增长到2030年的107亿美元;预计 2022 年至 2030 年复合年增长率为 4.1%。
市场洞察和分析师观点:
癫痫是一种慢性大脑疾病,会导致神经细胞活动紊乱,导致癫痫发作。其特征是反复发作,涉及身体的一部分或整个身体。癫痫发作会改变感觉、行为、意识和肌肉运动。癫痫可能是一种遗传性疾病,也可能是由于外伤或中风等后天性脑损伤引起的。由于患有癫痫的老年患者的脆弱性增加,消费者对治疗的需求将会增加。
推动癫痫市场增长的因素包括癫痫患病率上升和不断增加对癫痫疗法开发的投资。此外,近年来,治疗癫痫药物的批准量显着增加,标志着在应对严重癫痫发作带来的挑战方面向前迈出了重要一步。人们日益认识到有效治疗选择的必要性,以及研究人员和制药公司开发创新疗法的不懈努力,正在导致这些药物的开发和批准。此外,基因疗法作为一种有前景的治疗方法的发展可能会在未来几年带来显着的癫痫市场趋势。
增长驱动因素:
癫痫,也称为癫痫症,是一种慢性脑部疾病。这种情况可能是由于遗传性疾病或后天性脑损伤(例如外伤或中风)造成的。它的特点是反复发作,即身体某个部位或整个身体的不自主运动的短暂发作。癫痫发作会改变感觉、行为、肌肉运动和意识。根据世界卫生组织 (WHO) 2023 年 2 月发布的数据,癫痫在全球疾病负担中占有很大份额,影响着全球近 5000 万人。此外,估计每 1,000 人中有 4-10 人患有活动性癫痫(即需要治疗或持续癫痫发作)。每年有近 500 万人被诊断患有癫痫症。据估计,高收入国家每年每 10 万人中有 49 人患有癫痫。在低收入和中等收入国家,这一数字可高达每 10 万人 139 人。癫痫发病率的激增可归因于道路交通伤害和出生相关伤害的增加以及神经囊尾蚴病或疟疾等地方性疾病的风险增加。
世界卫生组织指出,大约 70% 的癫痫患者可能会成为癫痫患者。使用药物后无癫痫发作。控制癫痫的治疗方法包括抗癫痫药物、特殊饮食(除抗癫痫药物外)和手术;然而,抗癫痫药物治疗是大多数患者的主要治疗方法。因此,全球癫痫患病率的上升推动了预测期内癫痫市场的增长。
战略见解
报告细分和范围:
癫痫市场分析是通过考虑以下细分市场进行的:类型、给药途径、治疗类型、年龄组、分销渠道和地理位置。根据类型,市场分为进行性肌阵挛性癫痫、全身性癫痫、反射性癫痫等。从给药途径来看,市场上分为口服、肠胃外及其他。根据治疗类型,市场分为第一代药物、第二代药物和第三代药物。从年龄组来看,市场分为成人和儿童。
根据分销渠道,市场分为医院药房、零售药房等。癫痫市场报告的地理范围涵盖北美(美国、加拿大和墨西哥)、欧洲(法国、德国、英国、西班牙、意大利和欧洲其他地区)、亚太地区(中国、日本、印度、韩国、澳大利亚和亚太其他地区)、中东和非洲(沙特阿拉伯、阿联酋、南非以及中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷以及南美洲和中美洲其他地区) .
细分分析:
癫痫市场按类型分为进行性肌阵挛性癫痫、全身性癫痫、反射性癫痫等。 2022年,全身性癫痫细分市场占据最大市场份额。预计 2022 年至 2030 年期间复合年增长率将达到市场最高水平。全身性癫痫从一开始就涉及大脑中广泛的电干扰。这种情况经常会影响身体两侧,导致意识丧失。大脑两侧同时出现的癫痫发作是全身性癫痫的特征。全身性癫痫的治疗目标是调节和预防大脑过度电活动。这些疗法可能包含针对皮层和深部大脑区域的药物。 AED 被广泛用于治疗这种癫痫,从而解决了多种适应症。
癫痫市场,按类型 - 2022 年和 2030 年
根据给药途径,癫痫市场分为口服、肠胃外和其他。 2022年,口腔细分市场占据最大市场份额。该细分市场预计在 2022 年至 2030 年期间将以最高复合年增长率增长。口服给药是 AED 给药的重要途径,尤其是对于慢性癫痫患者。口服AED主要包括立即释放和改良释放(延迟释放和延长释放)剂型。口服药物使用方便,允许患者自行给药并遵守规定的治疗方案。与肌肉注射、静脉注射等其他给药途径相比,该途径因其简单而受到青睐。
根据治疗类型,癫痫市场分为第一代药物、第二代药物和第三代药物。 2022 年,第三代药物细分市场占据最大的癫痫市场份额。预计该细分市场在 2022 年至 2030 年期间复合年增长率最高。第三代AED被认为是先进或下一代AED,主要包括醋酸艾斯利卡西平、拉科酰胺和大麻二酚。据称,这些药物在安全性和有效性方面优于第一代和第二代 AED。大多数新型 AED 用于控制局灶性癫痫发作以及特定癫痫综合征(Lennox-Gastaut 综合征和 Dravet 综合征)和结节性硬化症。大多数第三代 AED 的不良反应较少,从而提高了患者治疗的依从性。这些药物对于儿童来说也是有效、安全且耐受性良好的。第三代药物越来越重要,但处方频率不如第二代抗癫痫药物。
根据年龄组,癫痫市场分为成人和儿童。 2022年,成人细分市场将占据更大的市场份额。预计 2022 年至 2030 年市场复合年增长率将更高。成人更容易患癫痫,因为这种疾病的一些危险因素在成人中更常见;这些疾病包括影响大脑功能的疾病(例如阿尔茨海默病)、脑肿瘤、中风和头部受伤。根据美国疾病控制与预防中心 (CDC) 的数据,美国有 300 万 18 岁或以上的成年人患有活动性癫痫症。其中近 100 万成年人年龄在 55 岁或以上。随着人口老龄化,未来几年可能会有更多老年人患有癫痫病。 2021 年,1.1% 的美国成年人(约 286 万名成年人)报告患有活动性癫痫。因此,药物和治疗策略通常优先考虑成年患者,与该年龄段癫痫的人口患病率保持一致。
根据分销渠道,市场分为医院药房、零售药房等。医院药房细分市场在 2022 年占据最大的癫痫市场份额。此外,零售药房细分市场预计在 2022 年至 2030 年期间将实现最高的复合年增长率。
区域分析:
癫痫的地理范围市场报告涵盖北美、欧洲、亚太地区、南美洲和中美洲以及中东和非洲。 2022 年,北美占据了很大的市场份额。北美市场的增长归因于受癫痫影响的人数增加、人口老龄化、癫痫治疗领域的持续研发、新产品的监管批准以及事故和脑损伤数量的增加。受伤。 2022 年,美国将占据该地区最大的市场份额。
根据 CDC 的数据,美国近 1.2% 的人患有活动性癫痫症。该国有 300 万成年人和 47 万儿童受到这种情况的影响。阿尔茨海默病等神经系统疾病病例数量的不断增加、人们对神经系统疾病的认识不断提高、研究活动取得的良好成果以及癫痫药物开发投资的增加是推动美国癫痫市场整体增长的主要因素。
2020 年 3 月,Neurelis, Inc. 宣布 VALTOCO(地西泮鼻喷雾剂)上市,用于治疗与儿科常见癫痫发作模式不同的频繁癫痫发作(即急性反复癫痫发作和丛集性癫痫发作)的刻板、间歇性发作和成年患者。同样,2022 年 3 月,FDA 批准 Ztalmy(加奈索龙)用于治疗 2 岁及以上患者与细胞周期蛋白依赖性激酶样 5 (CDKL5) 缺乏症 (CDD) 相关的癫痫发作。
2021 年 8 月,CDC 癫痫该计划根据一项新的合作协议选择癫痫基金会作为其资金接受者:通过国家和社区伙伴关系改善护理系统、癫痫教育和健康成果。未来 5 年将分配 1750 万美元的联邦资金,用于支持癫痫基金会及其合作伙伴的工作,创建和维护强大的公共卫生基础设施,促进健康公平,改善生活质量,并实现为所有癫痫患者带来最佳结果。因此,癫痫患病率的不断上升、新药上市以及研究和资助计划促进了美国癫痫市场的增长。
行业发展和未来机遇:
全球癫痫市场参与者采取的举措市场如下:
2024 年 1 月,卫材有限公司获得日本厚生劳动省批准在该国销售 Fycompa(吡仑帕奈)注射制剂。该产品被批准作为暂时无法口服给药时的替代疗法。例如,口服药物可能会导致手术期间癫痫发作的风险。因此,该公司开发了 Fycompa 的注射剂型,以提供一种新形式的药物,以及日本已上市的片剂和细颗粒剂型。 2023 年 5 月,Neuro3 Therapeutics (Neuro3),专注于寻找和创造治疗中枢神经系统疾病的新型药物,与灵北(丹麦)签署了独家全球许可和期权协议。该协议重点关注 KCNQ2 离子通道激活剂,该药物已被临床验证为癫痫治疗的靶点。竞争格局和主要公司:
癫痫市场预测可以帮助利益相关者规划其增长战略。雅培实验室、辉瑞公司、卫材有限公司、UCB SA、CombiGene AB、Livanova PLC、诺华公司、美敦力公司、葛兰素史克公司和 H. Lundbeck AS 是市场上的知名参与者。市场参与者专注于推出新的高科技产品、现有产品的进步以及地域扩张,以满足全球不断增长的消费者需求。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which segment is dominating the epilepsy market?

The global epilepsy market is segmented based on type, route of administration, treatment type, age group, distribution channel. The epilepsy market, by type, is categorized into progressive myoclonic epilepsy, generalized epilepsy, reflex epilepsy, and others. In 2022, the generalized epilepsy segment held the largest share of the market. It is expected to register the highest CAGR in the market during 2022–2030.

What was the estimated epilepsy market size in 2022?

The epilepsy market was valued at US$ 7.7 billion in 2022.

What are the growth estimates for the epilepsy market till 2030?

The epilepsy market is expected to be valued at US$ 10.7 billion in 2030.

Who are the major players in the epilepsy market?

The epilepsy market majorly consists of the players, including Abbott Laboratories, Pfizer Inc, Eisai Co Ltd, UCB SA, CombiGene AB, Livanova PLC, Novartis AG, Medtronic PLC, GSK PLC, and H. Lundbeck AS.

What is the driving and restraining factors for the epilepsy market?

The factors driving the growth of the epilepsy market include the rising prevalence of epilepsy and increasing investments in the development of epilepsy therapies. However, the recall of products hampers the growth of the epilepsy market.

What is epilepsy?

Epilepsy is a neurological condition that can cause seizures and affects millions of people globally. Epilepsy drugs are also known as anti-epileptic drugs (AEDs), which are commonly used for the treatment of epilepsy as it helps in the better management of seizures among epilepsy patients. Some of the patients with drugs resistance epilepsy opt for other treatment methods such as surgery and devices that are implanted in the brain to helps in seizure management.

The List of Companies - Epilepsy Market

  1. Abbott Laboratories
  2. Pfizer Inc
  3. Eisai Co Ltd
  4. UCB SA
  5. CombiGene AB
  6. Livanova PLC
  7. Novartis AG
  8. Medtronic PLC
  9. GSK PLC
  10. H. Lundbeck AS.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports